Skip to main content
. 2011 Nov 29;6(11):e28126. doi: 10.1371/journal.pone.0028126

Table 1. Anti-P. vivax antibody prevalence in Sanliurfa.

Antigen Antibody responses (nā€Š=ā€Š195)Number (%) IgG subclasses among IgG responders (%)
IgG IgM IgG+IgM IgG1 IgG2 IgG3 IgG4
PvMSP1 98 (50.3%) 55 (28.2%) 105 (53.6%) 93.9 11.2 70.4 5.1
PvAMA1-ecto 41 (21.0%) 35 (17.9%) 66 (33.7%) 95 7.5 77.5 7.5
PvSERA4 32 (16.4%) 96 (49.2%) 106 (54.1%) 90.6 15.6 59.4 12.5
PvCSP (chimeric) 66 (33.8%) 72 (36.9%) 88 (45%) 76.9 6.2 86.2 16.9
Total 121 (62.1%) 128 (65.6%) 155 (79.1%)